Sun, Dec 21, 2014, 1:31 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

  • flyingfishroe flyingfishroe Oct 16, 2006 11:03 PM Flag

    Medibic group

    What would you do when Glufosfamide fail to pass the phase 3 ? THLD's stock would be nothing then. Are you worry about it? Well, there is a way that you don't have to worry about such a risk and you still enjoy the Glufosfamide' dream.
    Let me introduce a Japanese bio tech company Medibic group who has the right to sell Glufosfamide to Asian market.
    Medibic G. and THLD agreed about joint development of anticancer agent in Asia in Dec.2004.They paid about $5 million to THLD for the royalties.
    The company established in 2000 and It is listed on the Stock Exchange to Tokyo Stock Exchange Mothers on September 2003.
    They have long been struggling with its finance and business manner in Japan. However they are widely expanding as a company,in Asia, and it seems like they are making a profit for the first time in their history by the end of this year even without Glufosfamide's sucssese, their newest IR on 10/16/2006 said so.
    For Medibic, Glufosfamide is huge hope but not the only hope.That is the defference from THLD. Do you see it ?
    They will be a big company with "Personalized Medicine´┐Ż to reality in Asia.
    What's good for investors these days are that their stock price is lowest in their history, actually till the newest IR showed up last Monday, and yen is so cheap to $,
    Well, take a look at their Web and think about it. One phone call may make you happier than you today! By the way,I have both of Medibic and THLD stocks.
    Good luck!
    http://www.medibic.com/en/index.html
    http://www.medibicalliance.com/en/

 
THLD
3.07-0.05(-1.60%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Under Armour, Inc.
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST